These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3620343)

  • 1. NK cell density in malignant skin tumours--a stereological study.
    Smolle J; Soyer HP; Ehall R; Stettner H; Kerl H
    Br J Dermatol; 1987 Jun; 116(6):823-9. PubMed ID: 3620343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin-producing cells in the inflammatory infiltrates of cutaneous tumors. Immunocytologic identification in situ.
    Bustamante R; Schmitt D; Pillet C; Thivolet J
    J Invest Dermatol; 1977 Jun; 68(6):346-9. PubMed ID: 325148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistological study of benign and malignant skin tumours: epithelial aspects.
    Gatter KC; Pulford KA; Vanstapel MJ; Roach B; Mortimer P; Woolston RE; Taylor-Papadimitriou J; Lane EB; Mason DY
    Histopathology; 1984 Mar; 8(2):209-27. PubMed ID: 6373555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symbiotic collision tumour of the scalp: squamous cell carcinoma and malignant melanoma.
    Mangkorntongsakul V; Tng ETV; Scurry J; Gourlay R
    Australas J Dermatol; 2020 May; 61(2):e229-e230. PubMed ID: 31885076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression in skin tumours: a common phenomenon.
    Barnetson RS; Halliday GM
    Australas J Dermatol; 1997 Jun; 38 Suppl 1():S63-5. PubMed ID: 10994476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face.
    Feller L; Khammissa RAG; Kramer B; Altini M; Lemmer J
    Head Face Med; 2016 Feb; 12():11. PubMed ID: 26850723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of CD16/NKH-1+ natural killer cells and their relevance to cutaneous tumour immunity.
    Markey AC; MacDonald DM
    Br J Dermatol; 1989 Nov; 121(5):563-70. PubMed ID: 2480804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and Phenotypic Characterization of Tumor-Infiltrating NK Cells in Skin Carcinoma.
    Arjmand B; Hamidpour SK; Tayanloo-Beik A; Arjmand R; Rezaei-Tavirani M; Aghayan H; Rajaeinejad M; Larijani B
    Methods Mol Biol; 2024; 2849():215-226. PubMed ID: 38329617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spindle cell tumours of the skin of debatable origin. An immunocytochemical study.
    Eusebi V; Ceccarelli C; Piscioli F; Cristofolini M; Azzopardi JG
    J Pathol; 1984 Nov; 144(3):189-99. PubMed ID: 6209370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutical options in malignant skin tumours].
    Stanisz H; Tilgen W; Rass K
    MMW Fortschr Med; 2009 Sep; 151(39):34-8. PubMed ID: 19831193
    [No Abstract]   [Full Text] [Related]  

  • 11. [31-P-spectroscopy as a method for studying biochemical changes in skin tumors: exemplified by malignant melanoma and squamous cell carcinoma].
    Kiricuta IC; Schmitt WG; Beyer HK
    Z Hautkr; 1988 Feb; 63(2):108, 111-2. PubMed ID: 3376511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ultrasound microscopy of skin sections].
    Buhles N; Altmeyer P
    Z Hautkr; 1988 Nov; 63(11):926-34. PubMed ID: 3070995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant melanoma and squamous cell carcinoma forming one tumour on a burn scar.
    Akiyama M; Inamoto N; Nakamura K
    Dermatology; 1997; 194(2):157-61. PubMed ID: 9094465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cytochalasin B on human malignant melanoma cells and squamous cell carcinoma cells in vitro.
    Kanzaki T; Hashimoto K
    J Dermatol; 1979 Dec; 6(6):351-8. PubMed ID: 396311
    [No Abstract]   [Full Text] [Related]  

  • 15. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
    Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
    Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple malignant melanoma and squamous-cell carcinoma in a burn scar.
    Ikeda I; Kageshita T; Ono T
    Dermatology; 1995; 191(4):328-32. PubMed ID: 8573933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronically neglected malignant skin tumours].
    Grosshans E
    Ann Dermatol Venereol; 2012 Mar; 139(3):180-2. PubMed ID: 22401681
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance.
    Paul P; Rouas-Freiss N; Khalil-Daher I; Moreau P; Riteau B; Le Gal FA; Avril MF; Dausset J; Guillet JG; Carosella ED
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4510-5. PubMed ID: 9539768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cells in cutaneous malignant melanoma.
    Kernohan NM; Sewell HF; Walker F
    J Pathol; 1990 May; 161(1):35-40. PubMed ID: 2196350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting natural killer cells for therapy of melanoma.
    Hölsken O; Miller M; Cerwenka A
    J Dtsch Dermatol Ges; 2015 Jan; 13(1):23-9. PubMed ID: 25640488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.